Answers are grounded in this paper and cite their sources.
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
No takes yet. Share an insight, caveat, or question.
Mehrtash et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: